Athira Pharma logo

Athira Pharma Share Price (NASDAQ: ATHA)

$0.4

Live

Last updated on

Check the interactive Athira Pharma Stock chart to analyse performance

Athira Pharma stock performance

as on August 20, 2025 at 11:41 PM IST

  • Today's Low:$0.40
    Today's High:$0.41

    Day's Volatility :3.52%

  • 52 Weeks Low:$0.22
    52 Weeks High:$3.51

    52 Weeks Volatility :93.75%

Athira Pharma Stock Returns

PeriodAthira Pharma IncSector (Health Care)Index (Russel 2000)
3 Months
45.25%
1.5%
0.0%
6 Months
-11.56%
-7.1%
0.0%
1 Year
-88.32%
-11.4%
0.0%
3 Years
-89.04%
2.9%
-9.6%

Athira Pharma Inc Key Stats

Check Athira Pharma key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.4
Open
$0.39
Today's High
$0.4094
Today's Low
$0.39
Market Capitalization
$15.5M
Today's Volume
$19.1K
52 Week High
$3.51
52 Week Low
$0.219549
Revenue TTM
$0.0
EBITDA
$-56.9M
Earnings Per Share (EPS)
$-1.54
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-103.8%

Stock Returns calculator for Athira Pharma Stock including INR - Dollar returns

The Athira Pharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Athira Pharma investment value today

Current value as on today

₹15,865

Returns

₹84,135

(-84.14%)

Returns from Athira Pharma Stock

₹88,024 (-88.02%)

Dollar Returns*

₹3,889 (+3.89%)

Indian investors sentiment towards Athira Pharma Stock

-45%

Period: Jul 20, 2025 to Aug 19, 2025. Change in 30 Days versus previous period

Search interest for Athira Pharma Stock from India on INDmoney has decreased by -45% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Athira Pharma Inc

  • Name

    Holdings %

  • Perceptive Advisors LLC

    13.70%

  • BML Capital Management LLC

    8.19%

  • Vanguard Group Inc

    3.90%

  • Propel Bio Management LLC

    3.79%

  • Simplify Asset Management Inc.

    3.79%

  • TANG CAPITAL MANAGEMENT LLC

    1.52%

Analyst Recommendation on Athira Pharma Stock

Rating
Trend

Buy

    66%Buy

    33%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Athira Pharma(by analysts ranked 0 to 5 stars)

Athira Pharma Share Price Target

What analysts predicted

Upside of 0.0%

Target:

$0.40

Current:

$0.40

Athira Pharma share price target is $0.40, a slight Upside of 0.0% compared to current price of $0.40 as per analysts' prediction.

Athira Pharma Stock Insights

  • Price Movement

    In the last 3 months, ATHA stock has moved up by 45.5%
  • ATHA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 63.3% return, outperforming this stock by 151.6%
  • ATHA vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.3% return, outperforming this stock by 201.8%

Athira Pharma Technicals Summary

Sell

Neutral

Buy

Athira Pharma is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Athira Pharma Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Athira Pharma Inc logo
-9.51%
-11.56%
-88.32%
-89.04%
-97.72%
Regeneron Pharmaceuticals, Inc. logo
4.65%
-16.73%
-52.11%
-6.73%
-5.71%
Beone Medicines Ltd logo
7.16%
32.17%
61.08%
80.84%
30.07%
Vertex Pharmaceuticals Incorporated logo
-14.79%
-17.19%
-19.84%
32.96%
44.01%
Alnylam Pharmaceuticals, Inc. logo
43.03%
83.01%
63.29%
110.39%
235.62%

About Athira Pharma Inc

Athira Pharma, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. Its product pipeline includes ATH-1105 for the treatment of amyotrophic lateral sclerosis, which is in phase 1 clinical trial; ATH-1020 for the treatment of neurodegenerative diseases, which is phase 1 clinical trial, as well as early compounds which is in preclinical phase. The company was formerly known as M3 Biotechnology, Inc. and changed its name to Athira Pharma, Inc. in April 2019. Athira Pharma, Inc. was incorporated in 2011 and is headquartered in Bothell, Washington.
Organization
Athira Pharma
Employees
26
CEO
Dr. Mark J. Litton M.B.A., Ph.D.
Industry
Commercial Services

Key Management of Athira Pharma Inc

NameTitle
Dr. Mark J. Litton M.B.A., Ph.D.
President, CEO & Director
Dr. Kevin Church Ph.D.
Chief Scientific Officer
Mr. Mark F. Worthington J.D.
General Counsel, Chief Compliance Officer & Corporate Secretary
Mr. Robert Renninger
Senior VP of Finance & Accounting, Principal Financial Officer and Principal Accounting Officer
Ms. Julie Rathbun
Head of Investor Relations
Dr. Javier San Martin M.D.
Chief Medical Officer

Important FAQs about investing in ATHA Stock from India :

What is Athira Pharma share price today?

Athira Pharma share price today is $0.40 as on . Athira Pharma share today touched a day high of $0.41 and a low of $0.40.

What is the 52 week high and 52 week low for Athira Pharma share?

Athira Pharma share touched a 52 week high of $3.51 and a 52 week low of $0.22. Athira Pharma stock price today i.e. is trending at $0.40, lower by 88.6% versus the 52 week high.

How to invest in Athira Pharma Stock (ATHA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Athira Pharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Athira Pharma Shares that will get you 3.7500 shares as per Athira Pharma share price of $0.40 per share as on August 20, 2025 at 11:41 PM IST.

What is the minimum amount required to buy Athira Pharma Stock (ATHA) from India?

Indian investors can start investing in Athira Pharma (ATHA) shares with as little as ₹87.0225 or $1 (as of August 20, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹870.22 in Athira Pharma stock (as per the Rupee-Dollar exchange rate as on August 20, 2025). Based on Athira Pharma share’s latest price of $0.40 as on August 20, 2025 at 11:41 PM IST, you will get 25.0000 shares of Athira Pharma. Learn more about fractional shares .

What are the returns that Athira Pharma has given to Indian investors in the last 5 years?

Athira Pharma stock has given -97.72% share price returns and 16.26% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?